THE INHIBITORY EFFECT OF NORADRENALINE ON THYROTROPIN-STIMULATED 3,5,3'-TRI-IODOTHYRONINE AND THYROXINE RELEASE IS MEDIATED THROUGH A CA2-DEPENDENT PROCESS IN THE THYROID-GLAND OF THE MOUSE()
Y. Oda et al., THE INHIBITORY EFFECT OF NORADRENALINE ON THYROTROPIN-STIMULATED 3,5,3'-TRI-IODOTHYRONINE AND THYROXINE RELEASE IS MEDIATED THROUGH A CA2-DEPENDENT PROCESS IN THE THYROID-GLAND OF THE MOUSE(), Journal of Endocrinology, 138(1), 1993, pp. 73-80
We examined the effect of noradrenaline on the release of 3,5,3'-tri-i
odothyronine (T3) and thyroxine (T4) from perifused mouse thyroid. Nor
adrenaline suppressed the thyrotrophin (TSH)-stimulated release of T3
and T4. The addition of prazosin, which is a specific alpha1 antagonis
t, or the depletion of Ca2+ from the perifusion buffer completely abol
ished the inhibitory effect of noradrenaline on TSH-stimulated T3 and
T4 release. Noradrenaline did not inhibit TSH-stimulated cyclic adenos
ine 3',5'-monophosphate (cAMP) release in the presence of 3-isobutyl-1
-methylxanthine (IBMX), which inhibits both cAMP-specific and calmodul
in-sensitive phosphodiesterases. Noradrenaline significantly suppresse
d the TSH-stimulated release of T3 and T4 in the presence of IBMX. The
se results suggest that the inhibitory effect of noradrenaline on TSH-
stimulated T3 and T4 release is not mediated through a cAMP-dependent
process or the activation of a calmodulin-sensitive phosphodiesterase,
and that this inhibition is mediated through a Ca2+-dependent process
regulated by the alpha1-adrenergic system in the mouse thyroid.